jazz pharmaceuticals plc
(JAZZ:NASDAQ GS)
JAZZ
Industry Average
Profitability - jazz pharmaceuticals plc (JAZZ)
|
Return on Assets Industry Comparison
11.58%
|
Return on Equity Industry Comparison
28.23%
|
|
|
Return on Capital Industry Comparison
14.04%
|
Margin Analysis - jazz pharmaceuticals plc (JAZZ)
|
Gross Margin Industry Comparison
88.10%
|
Levered Free Cash Flow Margin Industry Comparison
34.02%
|
|
|
EBITDA Margin Industry Comparison
51.45%
|
SG&A Margin Industry Comparison
33.60%
|
Asset Turnover - jazz pharmaceuticals plc (JAZZ)
|
Total Assets Turnover Industry Comparison
0.5x
|
Accounts Receivables Turnover Industry Comparison
9.1x
|
|
|
Fixed Assets Turnover Industry Comparison
138.4x
|
Inventory Turnover Industry Comparison
4.1x
|
Credit Ratios - jazz pharmaceuticals plc (JAZZ)
|
Current Ratio Industry Comparison
2.7x
|
Quick Ratio Industry Comparison
2.2x
|
Long-Term Solvency - jazz pharmaceuticals plc (JAZZ)
|
Total Debt/Equity Industry Comparison
38.8x
|
Total Liabilities/Total Assets Industry Comparison
42.2x
|
Growth Over Prior Year - jazz pharmaceuticals plc (JAZZ)
|
Total Revenue Industry Comparison
109.83%
|
Tangible Book Value Industry Comparison
-150.67%
|
|
|
EBITDA Industry Comparison
95.16%
|
Gross Profit Industry Comparison
95.46%
|
|
|
Receivables Industry Comparison
67.13%
|
Inventory Industry Comparison
34.36%
|
|
|
Diluted EPS Before Extra Industry Comparison
68.53%
|
Capital Expenditures Industry Comparison
356.21%
|
|
|
Cash From Ops. Industry Comparison
92.38%
|
Levered Free Cash Flow Industry Comparison
60.99%
|
| Recently Viewed | |||
| JAZZ:US | $63.75 USD | +0.75 |  |
| Company | Last | Change |
| Akorn Inc | $14.59 USD | 0.00 |
| Alkermes PLC | $32.84 USD | -0.16 |
| Salix Pharmaceuticals Ltd | $60.39 USD | +0.70 |
| Santarus Inc | $22.56 USD | -0.37 |
| ViroPharma Inc | $27.04 USD | +0.60 |
| View Industry Companies | ||
Industry Analysis
JAZZ
Industry Average
| Valuation | JAZZ | Industry Range |
| Price/Earnings | 14.0x |
|
| Price/Sales | 5.4x |
|
| Price/Book | 3.2x |
|
| Price/Cash Flow | 9.8x |
|
| TEV/Sales | 4.1x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact JAZZ PHARMACEUTICALS PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
